En Es
Categories

Industry News

Study Finds Most Healthcare Institutions Plan to Use AI and Develop Own AI Algorithm

By Medimaging International staff writers
30 Jan 2020

IllustrationA new study of healthcare professionals has revealed that Artificial Intelligence (AI) is widely expected to drive important benefits across the health system, from increasing efficiency to improving patient outcomes, but may also be the key to making healthcare more human. AI’s benefits range from increasing the amount of time clinicians can spend with patients and on cross-care team collaboration to enhancing the ability to deliver preventative care.

The study of more than 900 healthcare professionals in the US and UK was conducted by MIT Technology Review Insights along with GE Healthcare (Chicago, IL, USA).

MIT Technology Review Insights is the custom publishing division of the MIT Technology Review technology magazine, and conducts qualitative and quantitative research and analysis, and publishes a wide variety of content, including articles, reports, infographics, videos, and podcasts. GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, enabling precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.

Based on the study, which examined how AI is currently impacting healthcare professionals and the patients they serve today, roadblocks to adoption and opportunities for the future, GE Healthcare and MIT Technology Review Insights found that AI implementation is pervasive with seven out of 10 healthcare providers already adopting or considering adopting AI. Nearly half of the medical professionals surveyed said that AI is already increasing their ability to spend time with and provide care to patients. Additionally, more than 78% of healthcare business leaders who reported they have deployed AI in their operations also reported that AI has helped drive workflow improvements, streamlining operational and administrative activities and delivering significant efficiencies toward transforming the future of healthcare.

Among those surveyed, 81% believed that AI would improve their performance by making them more competitive, and 80% believed that it is already helping or will help them improve revenues. Even more notably, institutions that have already implemented AI technologies reported that it was playing a key part in rebalancing physician workload from administrative to patient-focused tasks, resulting in more time with patients and collaborating with colleagues across healthcare disciplines. The respondents stated that core administrative tasks, such as updating electronic records, can take up to 10%of their typical work week. Conversely, respondents at institutions with robust AI deployments indicated that they spend nearly 66% less time writing reports than their counterparts. Additionally, 45% of medical professionals said that AI has allowed them to increase time for patient consultations and to perform surgeries. Almost half said that AI would enable more robust diagnoses and more focus on preventative medicine.

AI has also helped alleviate a significant challenge for healthcare providers and institutions facing a rise in health worker burnout over the past decade. In fact, 80% of those surveyed indicated that AI had been instrumental in helping to remove barriers and reduce worker burnout. This paves the way for future improvements as AI-enabled technology scales across organizations to help improve data analysis, enable better diagnoses and treatment predictions, and further free medical staff from administrative burdens. Additionally, the vast majority of survey respondents believe that AI represents the extension – not extinction – of professional capabilities in healthcare.

Some other key survey findings included medical professionals using AI applications seeing immediate gains in reducing clinical error; 75% of medical staff who have AI stating that it has enabled better predictions in the treatment of disease; 78% reported that their AI deployments have already created workflow improvements; 60% of AI-empowered medical staff expect to spend more time performing procedures versus administrative or other work; and 68% spend more time collaborating with other staff and across clinical care areas, leading to potential benefits in patient care and precision health.

These trends are only expected to grow with survey results indicating that nearly 80% of healthcare institutions plan to increase their spending on AI in the next two years, including diverse technologies ranging from medical imaging and diagnostics to patient data and risk analytics. Further, nearly three in four healthcare institutions that use or plan to use AI will develop their own AI algorithms in the next two years.

“Today, AI is being deployed at a scale where we can move from speculating about its potential for healthcare to tracking it,” said Kieran Murphy, President and CEO, GE Healthcare. “From increasing the time healthcare providers can spend with patients to advancing preventative care, we are tremendously encouraged by the trends emerging across the health ecosystem. As a company at the forefront of healthcare data analytics and AI, we believe this is just the tip of the iceberg in terms of how intelligent technology will transform lives.”

Related Links:
GE Healthcare



E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

11 Jan 2023
GE HealthCare Acquires CT Navigation Innovator in France
GE HealthCare (Chicago, IL, USA) has entered into an agreement to acquire IMACTIS (Grenoble, France), an innovator in the rapidly growing field of computed tomography (CT) interventional guidance across an array of care areas.
Read More
05 Dec 2022
New Collaboration to Bring AR to Medical Imaging for Interventional Space
GE Healthcare (Chicago, IL, USA) and MediView XR, Inc. (Cleveland, OH, USA) have entered into a collaboration to integrate medical imaging into mixed reality solutions through the development of the OmnifyXR Interventional Suite System.
Read More
13 Oct 2022
GE Files Registration Statement for Planned Spin-Off of GE HealthCare
GE (Boston, MA, USA) has announced the filing of the Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) for the planned spin-off of its Healthcare division, to be called GE HealthCare.
Read More
20 Jul 2022
GE's Healthcare Business to Be Named GE HealthCare
GE (Boston, MA, USA) has announced that GE HealthCare will be the name of its healthcare business following its planned separation into three industry-leading, global, investment-grade public companies.
Read More
29 Apr 2022
GE Healthcare and Medtronic Collaborate to Improve Product Access for ASCs and OBLs
GE Healthcare (Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
23 Dec 2021
GE Healthcare Completes Acquisition of BK Medical to Expand Its Ultrasound Business
GE Healthcare (Chicago, IL, USA) has completed its previously announced acquisition of BK Medical (Peabody, MA, USA; www.bkmedical.com) in a deal that would expand its ultrasound business from diagnostics into surgical and therapeutic interventions.
Read More
13 Nov 2021
GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health
General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023.
Read More
30 Sep 2021
GE Healthcare Acquires BK Medical to Expand Ultrasound Portfolio into Surgical Visualization
GE Healthcare (Chicago, IL, USA) has entered into an agreement to acquire BK Medical (Peabody, MA, USA) in a deal that is expected to create value by further strengthening BK, including through significant synergies with the benefit of GE’s technology and commercial scale.
Read More

Additional news

25 Jan 2023
Global Diagnostic Imaging Services Market Driven by Rising Prevalence of Chronic Diseases
The global diagnostic imaging services market was valued at USD 40.80 billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period 2022-2030 to reach USD 67.94 billion in 2030, driven by the rising prevalence of chronic diseases, increasing elderly population, and rapid technological advancements in the healthcare diagnostic industry.
Read More
25 Jan 2023
Global Endoscopy Equipment Market Driven by Growing Hospital Investment in Advanced Instruments
The global endoscopy equipment market is projected to register a CAGR of 7% from USD 28.9 billion in 2022 to USD 40.6 billion by 2027, driven by increasing demand for endoscopy to diagnose and treat target diseases, rising investments, funds, and grants by governments and other organizations across the world, and growing focus by hospitals on investing in technologically-advanced endoscopy instruments and expanding endoscopy units.
Read More
25 Jan 2023
Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032
The global point-of-care (POC) glucose testing market is projected to register a CAGR of 4.3% during the forecast period from 2022 to 2032 to reach USD 5.8 billion by 2032, driven by a rise in the geriatric population, speed & precision of POC screening, increased adoption of electronic medical information, and the higher risk of COVID-19-related mortality associated with diabetes.
Read More
24 Jan 2023
Carolina Liquid Chemistries and Diazyme Enter Into Partnership
Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) and Diazyme Laboratories, Inc. (San Diego, CA, USA) have entered into a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer, allowing it to run both special and routine chemistries.
Read More
23 Jan 2023
Mindray Defibrillators Amongst the World’s First to Receive MDR Clearance
Mindray has received the CE marking for its defibrillation product family under the European Union's newest Medical Device Regulation (MDR). With the new rule tightening the controls for defibrillation devices, Mindray has become among the first manufacturers in the world to earn MDR accreditation for product quality and effectiveness.
Read More
23 Jan 2023
Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland
Siemens Healthineers has launched a Center of Excellence for Immunoassay Instrument Research and Development (R&D) in Swords, Ireland. The new center will focus on unlocking breakthrough innovations in laboratory instruments used to detect infectious diseases, cancer and blood disorders.
Read More
20 Jan 2023
Global Intensive Care Unit (ICU) Equipment Market Driven By Increasing Neurological Diseases
The global intensive care unit (ICU) equipment market was valued at USD 6.6 billion in 2021 and is estimated to register a CAGR of 3.9% from 2022 to 2031 to reach USD 9.6 billion by 2031, driven primarily by a rise in the prevalence of neurological diseases.
Read More
20 Jan 2023
Bayer Acquires Imaging AI Platform Provider in the UK
Bayer (Leverkusen, Germany) has acquired Blackford Analysis Ltd. (Edinburgh, UK), a global strategic imaging AI platform and solutions provider. The acquisition is part of Bayer's strategy to drive innovation in radiology, including the development and adoption of AI within the clinical workflow, with the goal to ultimately improve patient care and advance the company’s position in digital medical imaging.
Read More
16 Jan 2023
Medlab Middle East Sees 100% Increase in Exhibitor Numbers
Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, has sold out its exhibitor space ahead of the show, which returns to the Dubai World Trade Centre from February 6 to 9, 2023.
Read More
Copyright © 2000-2023 TradeMed.com. All rights reserved. | Terms And Conditions